RT Journal Article
SR Electronic
T1 2022-RA-656-ESGO H-SIL in young patients
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP A19
OP A20
DO 10.1136/ijgc-2022-ESGO.43
VO 32
IS Suppl 2
A1 Elga López González
A1 Carmen Cabanillas Apolo
A1 Maria Dolores Rodriguez Garnica
YR 2022
UL http://ijgc.bmj.com/content/32/Suppl_2/A19.3.abstract
AB Introduction/Background H-SIL in patients under 30 is increasing in recent years, and its management is sometimes controversial.Methodology Retrospective descriptive study that covers the period between January 2020 and December 2020, in which those patients under 30 years of age referred for any cytological alteration are studied, and that after colposcopy and biopsy a result of CIN II – CIN III is obtained. . Only those patients treated by conization have been selected.Results A total of 10 patients were included in the study. Of the patients in whom the cervical biopsy after colposcopy showed CIN-II (7 patients), 85.7% (N=6) presented CIN-II in the conization specimen and 14.3% (N=1) presented CIN -YO. Of those who had CIN-III in the postcolposcopy biopsy (3 patients), 66.7% (N=2) presented CIN-II in the conization piece and 33.3% (N=1) presented moderately differentiated infiltrating squamous cell carcinoma with resection ends widely affected by neoplasia.Conclusion The presence of preinvasive lesions in women under 30 years of age is a health problem in our environment. Perhaps we should investigate more on this topic to find some evidence that leads us to an action plan that leads to change.